These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation. Frank-Raue K; Raue F Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387 [TBL] [Abstract][Full Text] [Related]
4. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer. Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma. Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251 [TBL] [Abstract][Full Text] [Related]
6. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [TBL] [Abstract][Full Text] [Related]
7. Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment. Dabelić N; Jukić T; Fröbe A Acta Clin Croat; 2020 Jun; 59(Suppl 1):50-59. PubMed ID: 34219884 [TBL] [Abstract][Full Text] [Related]
13. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of medullary thyroid carcinoma. Massoll N; Mazzaferri EL Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557 [TBL] [Abstract][Full Text] [Related]
15. Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma. Raue F; Frank-Raue K J Endocr Soc; 2018 Aug; 2(8):933-943. PubMed ID: 30087948 [TBL] [Abstract][Full Text] [Related]
16. [The treatment of medullary thyroid cancer]. Fujita T; Fujimori M Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021 [TBL] [Abstract][Full Text] [Related]
17. [Medullary thyroid carcinoma in children]. Berdelou A; Hartl D; Al Ghuzlan A; Mirghani H; Chougnet C; Baudin E; Schlumberger M; Leboulleux S Bull Cancer; 2013; 100(7-8):780-8. PubMed ID: 23831771 [TBL] [Abstract][Full Text] [Related]
18. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation. González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565 [TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274 [TBL] [Abstract][Full Text] [Related]